197 related articles for article (PubMed ID: 31353451)
1. Long-term therapy with anakinra in hidradenitis suppurativa in three patients.
André R; Marescassier H; Gabay C; Pittet B; Laffitte E
Int J Dermatol; 2019 Nov; 58(11):e208-e209. PubMed ID: 31353451
[No Abstract] [Full Text] [Related]
2. Treatment of hidradenitis suppurativa with biologic medications.
Lee RA; Eisen DB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
[TBL] [Abstract][Full Text] [Related]
3. Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa.
Russo V; Alikhan A
J Drugs Dermatol; 2016 Jun; 15(6):772-4. PubMed ID: 27272089
[TBL] [Abstract][Full Text] [Related]
4. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
Leslie KS; Tripathi SV; Nguyen TV; Pauli M; Rosenblum MD
J Am Acad Dermatol; 2014 Feb; 70(2):243-51. PubMed ID: 24314876
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of severe hidradenitis suppurativa with anakinra.
Zarchi K; Dufour DN; Jemec GB
JAMA Dermatol; 2013 Oct; 149(10):1192-4. PubMed ID: 23966107
[No Abstract] [Full Text] [Related]
6. Two cases of severe hidradenitis suppurativa with failure of anakinra therapy.
Menis D; Maroñas-Jiménez L; Delgado-Marquez AM; Postigo-Llorente C; Vanaclocha-Sebastián F
Br J Dermatol; 2015 Mar; 172(3):810-1. PubMed ID: 25059730
[No Abstract] [Full Text] [Related]
7. Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa.
Oskardmay AN; Miles JA; Sayed CJ
J Am Acad Dermatol; 2019 Sep; 81(3):702-708. PubMed ID: 31095972
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option.
Hotz C; Sbidian E; Ingen-Housz-Oro S; Chosidow O; Wolkenstein P
Acta Derm Venereol; 2019 Nov; 99(12):1170-1171. PubMed ID: 31314122
[No Abstract] [Full Text] [Related]
9. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.
Tzanetakou V; Kanni T; Giatrakou S; Katoulis A; Papadavid E; Netea MG; Dinarello CA; van der Meer JWM; Rigopoulos D; Giamarellos-Bourboulis EJ
JAMA Dermatol; 2016 Jan; 152(1):52-59. PubMed ID: 26579854
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.
Schuch A; Fischer T; Boehner A; Biedermann T; Volz T
Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952
[No Abstract] [Full Text] [Related]
11. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M
Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847
[No Abstract] [Full Text] [Related]
12. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
[TBL] [Abstract][Full Text] [Related]
13. Infliximab for the treatment of hidradenitis suppurativa.
Fernández-Vozmediano JM; Armario-Hita JC
Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
[TBL] [Abstract][Full Text] [Related]
14. Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
Prussick L; Rothstein B; Joshipura D; Saraiya A; Turkowski Y; Abdat R; Alomran A; Zancanaro P; Kachuk C; Dumont N; Gottlieb AB; Rosmarin D
Br J Dermatol; 2019 Sep; 181(3):609-611. PubMed ID: 30801662
[No Abstract] [Full Text] [Related]
15. [Anakinra therapy in a patient with multifocal pyoderma gangrenosum and hidradenitis suppurativa].
Oymanns M; Kreuter A; Assaf C
Hautarzt; 2021 May; 72(5):435-438. PubMed ID: 33095334
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
Vekic DA; Frew JW
Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
[No Abstract] [Full Text] [Related]
17. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience.
Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M
Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378
[No Abstract] [Full Text] [Related]
18. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
Harde V; Mrowietz U
J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
[TBL] [Abstract][Full Text] [Related]
19. Infliximab for the treatment of hidradenitis suppurativa.
Lebwohl B; Sapadin AN
J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S275-6. PubMed ID: 14576652
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
